The European Union has made a contribution of €20 million to the Palestinian Authority to support the cost of COVID-19 vaccines authorised by the European Medicines Agency (EMA) and purchased by the Palestinian Authority.
The reimbursement of costs incurred for the purchase of COVID-19 vaccines will help the Palestinian Authority to meet part of its financial obligations towards its citizens amid the difficult fiscal situation. It will notably support the Palestinian Authority to respond to COVID-19 pandemic, which is still present, while alleviating its financial burden and consequences.
“We have been at the forefront of the international efforts to curb the pandemic by ensuring access to vaccines across the globe, including here in Palestine. The EU contributed, in this respect, both by contributing to the global initiative ‘COVAX’ which Palestine benefited from, and with the EUR 20 million support to the Palestinian COVID-19 vaccination campaign, as direct financial support provided to the Palestinian Authority. With this payment, the EU reaffirms its commitment to support the building of accountable institutions ready for an independent, democratic and viable future Palestinian state”, said the Deputy European Union Representative Maria Velasco.
For more information